Alcorn Harry W Jr - Net Worth and Insider Trading

Alcorn Harry W Jr Net Worth

The estimated net worth of Alcorn Harry W Jr is at least $183,621 dollars as of 2024-11-08. Alcorn Harry W Jr is the SVP, Clinical Operations of DiaMedica Therapeutics Inc and owns about 43,981 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $183,621. Details can be seen in Alcorn Harry W Jr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alcorn Harry W Jr has not made any transactions after 2021-09-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Alcorn Harry W Jr

To

Alcorn Harry W Jr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alcorn Harry W Jr owns 1 companies in total, including DiaMedica Therapeutics Inc (DMAC) .

Click here to see the complete history of Alcorn Harry W Jr’s form 4 insider trades.

Insider Ownership Summary of Alcorn Harry W Jr

Ticker Comapny Transaction Date Type of Owner
DMAC DiaMedica Therapeutics Inc 2021-09-15 Chief Medical Officer

Alcorn Harry W Jr Latest Holdings Summary

Alcorn Harry W Jr currently owns a total of 1 stock. Alcorn Harry W Jr owns 43,981 shares of DiaMedica Therapeutics Inc (DMAC) as of September 15, 2021, with a value of $183,621.

Latest Holdings of Alcorn Harry W Jr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DMAC DiaMedica Therapeutics Inc 2021-09-15 43,981 4.18 183,621

Holding Weightings of Alcorn Harry W Jr


Alcorn Harry W Jr Form 4 Trading Tracker

According to the SEC Form 4 filings, Alcorn Harry W Jr has made a total of 2 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 15,000 shares on September 15, 2021, which cost Alcorn Harry W Jr around $57,000.

Insider Trading History of Alcorn Harry W Jr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alcorn Harry W Jr Trading Performance

GuruFocus tracks the stock performance after each of Alcorn Harry W Jr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alcorn Harry W Jr is 11.84%. GuruFocus also compares Alcorn Harry W Jr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alcorn Harry W Jr within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alcorn Harry W Jr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alcorn Harry W Jr

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.61 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.24 LIMIT LIMIT LIMIT LIMIT LIMIT

Alcorn Harry W Jr Ownership Network

Ownership Network List of Alcorn Harry W Jr

No Data

Ownership Network Relation of Alcorn Harry W Jr

Insider Network Chart

Alcorn Harry W Jr Owned Company Details

What does DiaMedica Therapeutics Inc do?

Who are the key executives at DiaMedica Therapeutics Inc?

Alcorn Harry W Jr is the Chief Medical Officer of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include 10 percent owner Koch Thomas Von , 10 percent owner Jan Stahlberg , and CFO and Secretary Scott Kellen .

DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary

Over the past 18 months, Alcorn Harry W Jr made no insider transaction in DiaMedica Therapeutics Inc (DMAC). Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 2,670,588 shares made by Koch Thomas Von , a net purchase of 58,364 shares made by David J. Wambeke , and a net purchase of 1,200,000 shares made by Jan Stahlberg .

In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 4,067,889 shares were bought by its insiders, resulting in a net purchase of 4,067,889 shares.

DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

DiaMedica Therapeutics Inc Insider Transactions

No Available Data

Alcorn Harry W Jr Mailing Address

Above is the net worth, insider trading, and ownership report for Alcorn Harry W Jr. You might contact Alcorn Harry W Jr via mailing address: 2 Carlson Parkway, Suite 260, Minneapolis Mn 55447.